Nabriva Therapeutics plc
NBRVF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57,185 | -$49,450 | -$69,484 | -$82,764 |
| Dep. & Amort. | $217 | $637 | $820 | $770 |
| Deferred Tax | $0 | $0 | $2,757 | $0 |
| Stock-Based Comp. | $1,967 | $3,291 | $5,219 | $9,748 |
| Change in WC | $13,733 | -$14,857 | -$11,391 | -$195 |
| Other Non-Cash | $4,557 | $822 | $748 | $549 |
| Operating Cash Flow | -$36,711 | -$59,557 | -$71,331 | -$71,892 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$211 | -$25 | -$113 | -$61 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$52 | -$56 | -$161 | $392 |
| Investing Cash Flow | -$263 | -$81 | -$274 | $331 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,921 | $0 | -$30,000 | $9,980 |
| Stock Issued | $2,123 | $27,911 | $53,460 | $20,138 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,649 | $38,455 | $3,464 | $25,957 |
| Financing Cash Flow | $1,851 | $66,366 | $26,924 | $56,075 |
| Forex Effect | -$174 | -$484 | -$140 | -$106 |
| Net Chg. in Cash | -$35,297 | $6,244 | -$44,821 | -$15,592 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $47,834 | $41,590 | $86,411 | $102,003 |
| End Cash | $12,537 | $47,834 | $41,590 | $86,411 |
| Free Cash Flow | -$36,922 | -$59,582 | -$71,444 | -$71,953 |